Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring kidney allograft rejection: A proof-of-concept study using spatial transcriptomics.
Martin-Martin C, Suarez-Alvarez B, González M, Torres IB, Bestard O, Martín JE, Barceló-Coblijn G, Moreso F, Aransay AM, Lopez-Larrea C, Rodriguez RM. Martin-Martin C, et al. Among authors: gonzalez m. Am J Transplant. 2024 Apr 29:S1600-6135(24)00287-9. doi: 10.1016/j.ajt.2024.04.015. Online ahead of print. Am J Transplant. 2024. PMID: 38692412
Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma.
Gattlen C, Frank KR, Marie DN, Trompette A, Chriqui LE, Hao Y, Abdelnour E, Gonzalez M, Krueger T, Dyson PJ, Siankevich S, von Garnier C, Ubags NDJ, Cavin S, Perentes JY. Gattlen C, et al. Among authors: gonzalez m. JTCVS Open. 2024 Feb 17;18:324-344. doi: 10.1016/j.xjon.2024.02.007. eCollection 2024 Apr. JTCVS Open. 2024. PMID: 38690424 Free PMC article.
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.
Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, Fernandez-Mercado M, Larrayoz MJ, Gutierrez NC, Fernandez-Guijarro M, Gonzalez-Calle V, Rodriguez-Otero P, Oriol A, Rosiñol L, Alegre A, Escalante F, De La Rubia J, Teruel AI, De Arriba F, Hernandez MT, Lopez-Jimenez J, Ocio EM, Puig N, Paiva B, Lahuerta JJ, Bladé J, San Miguel JF, Mateos MV, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R; GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. Medina-Herrera A, et al. Blood Cancer J. 2024 Apr 29;14(1):74. doi: 10.1038/s41408-024-01053-3. Blood Cancer J. 2024. PMID: 38684670 Free PMC article. Clinical Trial.
[Inflammageing in patients with idiopathic pulmonary fibrosis (IPF)].
Rodríguez-Rodríguez I, Mesa-Gallo BL, Rico-Puentes Y, González M, Parra-López CA. Rodríguez-Rodríguez I, et al. Among authors: gonzalez m. Rev Alerg Mex. 2024 Feb 1;71(1):72. doi: 10.29262/ram.v71i1.1350. Rev Alerg Mex. 2024. PMID: 38683089 Spanish.
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
Yang L, Murthy S, Cortellini A, Lim EA, Gonzalez M, Pinato DJ, Abdel-Malek M, Mahmoud S, Martin NM. Yang L, et al. Among authors: gonzalez m. Front Endocrinol (Lausanne). 2024 Apr 12;15:1369268. doi: 10.3389/fendo.2024.1369268. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38681767 Free PMC article.
7,839 results